Montreal attorneys try to trademark 'COVID-19'
Two Montreal lawyers have applied to register the term “COVID-19” as a trademark, a bid that experts say is unlikely to succeed.
Meriem
Amir and Giovanni De Sua filed applications on March 25 to register the
name of the disease caused by the novel coronavirus as well as the
terms “prevention and care COVID-19,” according to the trademark
database of the Canadian Intellectual Property Office.
The
lawyers, who don't appear on the federal government's database of
trademark attorneys, said in their request that the use of the term
would be linked to vaccines.
They did not respond to interview
requests but colleagues specializing in this area of law said they don't
understand why someone would try to register the disease's name.
“These
trademarks will probably never be registered in Canada,” said David
Lipkus, a trademark attorney with Toronto-based Kesternberg Siegal
Lipkus.
Lipkus said it usually takes two years before a decision is made, a timeframe which could be extended due to the pandemic.
“A
trademark must pass several tests before being registered, including
whether the term is descriptive or distinctive,” he said. “Trying to
register 'COVID-19' as a brand would be equivalent to registering
'cancer' or 'diabetes.'”
Alan Macek, another Toronto lawyer, said he isn't surprised to see someone try to register “COVID-19” as a trademark.
“We often see such a wave when there is something new in the news and people talk about it,” he said.
Macek
said trademarks are generally accepted for a coined term or combination
of words that could include “COVID” but should then be distinct from
the name of the virus itself.
The two lawyers aren't alone. On
April 7, Nova Scotia medical testing company MedMira applied to register
the trademark “REVEALCOVID-19” for “a rapid serological test that would
detect antibodies made to fight the novel coronavirus.”
The American patent and trademark agency has also seen an incease in COVID-related application, according to Lipkus.
-
Previous:
-
Next: